Roquette America and Quadra Ingredients Enter Partnership
Roquette America and Quadra Ingredients enter a partnership for the distribution of pharmaceutical products in Canada.
Roquette America
and Quadra Ingredients have entered apartnership for the distribution of pharmaceutical and personal care products in Canada.
The product range from Roquette provides solutions forformulators by addressing challenges such as enhancing stability, taste masking, organoleptic and disintegration enhancements, sugar-free delivery systems, clean label coatings, and cost reductions through improved performance. The product line includes excipients for use in various delivery systems used by the pharmaceutical, nutraceutical, and personal care markets, including tablets, capsules, soft gels, suspensions, liquids, powders, creams and ointments, orally dispersible tablets, and orally dispersible tablets, and parenteral.
Quadra Ingredients has a specialized sales and marketing team that will provide technical and regulatory support.
Source:
Roquette America
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
